Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Cilostazol-d11, 1073608-02-2
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Cilostazol-d11 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Cilostazol-d11 usage and description
Cilostazol D11 is a deuterated isotopologue of cilostazol, a medication that is used to treat intermittent claudication. Intermittent claudication is a condition in which there is pain and cramping in the legs during physical activity. Cilostazol D11 works by increasing blood flow to the legs, which reduces the pain and cramping associated with intermittent claudication.
Cilostazol D11 is a phosphodiesterase III inhibitor. It works by inhibiting the enzyme phosphodiesterase III, which leads to an increase in the levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in the body. This increase in cAMP and cGMP leads to vasodilation and inhibition of platelet aggregation, which improves blood flow to the legs.
The chemical formula of cilostazol D11 is C20H14D11N5O2S, and its molecular weight is 409.53 g/mol. It is a white to off-white crystalline powder that is insoluble in water and soluble in ethanol and dimethyl sulfoxide.
Cilostazol D11 is administered orally, usually in a tablet form. The recommended dosage is usually 100 mg twice daily. It is important to follow the dosage instructions provided by the healthcare provider to ensure that the medication is effective and safe. Like any medication, Cilostazol D11 may cause side effects such as headache, diarrhea, dizziness, and palpitations. If any of these side effects persist or worsen, it is important to contact a healthcare provider immediately.
